Which should you choose? Here's what you need to know.
Retatrutide and Survodutide are both weight loss (glp-1) peptides, but they work differently. A next-generation triple agonist (GLP-1/GIP/glucagon) in clinical trials showing significant weight loss results. Considered the most promising obesity peptide in development. A dual GLP-1/glucagon receptor agonist being developed by Boehringer Ingelheim for obesity and metabolic liver disease. Compare vendor pricing and availability below.
A next-generation triple agonist (GLP-1/GIP/glucagon) in clinical trials showing significant weight loss results. Considered the most promising obesity peptide in development.
A dual GLP-1/glucagon receptor agonist being developed by Boehringer Ingelheim for obesity and metabolic liver disease.
Once you've decided which peptide fits your needs, here's how they compare on price and vendor options.
Our top-rated vendor for each, based on trust scores, purity testing, and price.
Some outbound links may earn us a commission. Vendors cannot pay to improve rankings.
Best Retatrutide Vendor
$220.00(40mg)
Best Survodutide Vendor
$74.99(10mg)
We check vendor prices every day and pull in real purity test results from independent labs — not vendor claims. No vendor can pay to rank higher. See our full methodology.